Clal Biotechnology Industries Ltd.
CBI.TA
Price:
$31.5
Market Cap:
$49.41M
Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It invests between $0.5 million and $10 million per company. It takes a seat on the board of directors of the companies it invests in. It invests through personal capital of its management. The firm acts as a lead investor and major shareholder i...[Read more]
Industry
Biotechnology
IPO Date
2007-06-04
Stock Exchange
TLV
Ticker
CBI.TA
PE Ratio
[-1.50]
ROE
[-104.31%]
Current Ratio
[0.11]
Dividend Yield
[0%]
Enterprise Value
[66.50M]
Dividend History
The Current Ratio as of December 2025 (TTM) for Clal Biotechnology Industries Ltd. (CBI.TA) is 0.11
According to Clal Biotechnology Industries Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 0.11. This represents a change of -43.30% compared to the average of 0.20 of the last 4 quarters.
Clal Biotechnology Industries Ltd. (CBI.TA) Historical Current Ratio (quarterly & annually)
How has CBI.TA Current Ratio performed in the past?
The mean historical Current Ratio of Clal Biotechnology Industries Ltd. over the last ten years is 4.04. The current 0.11 Current Ratio has changed 183.71% with respect to the historical average. Over the past ten years (40 quarters), CBI.TA's Current Ratio was at its highest in in the December 2020 quarter at 7.46. The Current Ratio was at its lowest in in the March 2025 quarter at 0.11.
Average
4.04
Median
3.98
Minimum
0.29
Maximum
7.46
Clal Biotechnology Industries Ltd. (CBI.TA) Current Ratio by Quarter and Year
Discovering the peaks and valleys of Clal Biotechnology Industries Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 162.48%
Maximum Annual Current Ratio = 7.46
Minimum Annual Increase = -86.86%
Minimum Annual Current Ratio = 0.29
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 0.29 | -86.86% |
| 2023 | 2.21 | -61.41% |
| 2022 | 5.71 | 162.48% |
| 2021 | 2.18 | -70.84% |
| 2020 | 7.46 | 123.10% |
| 2019 | 3.35 | -43.04% |
| 2018 | 5.87 | -1.11% |
| 2017 | 5.94 | 111.96% |
| 2016 | 2.80 | -39.16% |
| 2015 | 4.61 | -34.56% |
Clal Biotechnology Industries Ltd. (CBI.TA) Average Current Ratio
How has CBI.TA Current Ratio performed in the past?
The current Current Ratio of Clal Biotechnology Industries Ltd. (CBI.TA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.74
5-year avg
3.57
10-year avg
4.04
Clal Biotechnology Industries Ltd. (CBI.TA) Current Ratio vs. Peers
How is CBI.TA’s Current Ratio compared to its peers?
Clal Biotechnology Industries Ltd.’s Current Ratio is less than BioLineRx Ltd. (2.06), less than Can-Fite BioPharma Ltd. (3.60), less than Evogene Ltd. (1.89), less than XTL Biopharmaceuticals Ltd. (0.61), less than BioLight Life Sciences Ltd. (4.49), less than Together Pharma Ltd (1.11), less than Enlivex Therapeutics Ltd. (6.43), less than Matricelf Ltd (2.69), less than Tikun Olam-Cannbit Pharmaceuticals Ltd (0.20), less than PlantArc Bio Ltd. (10.51),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.06 | $42.86M | |
| 3.60 | $51.22M | |
| 1.89 | $28.94M | |
| 0.61 | $23.80M | |
| 4.49 | $19.70M | |
| 1.11 | $58.11M | |
| 6.43 | $65.62M | |
| 2.69 | $96.20M | |
| 0.20 | $28.21M | |
| 10.51 | $7.32M |
Build a custom stock screener for Clal Biotechnology Industries Ltd. (CBI.TA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clal Biotechnology Industries Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Clal Biotechnology Industries Ltd. (CBI.TA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Clal Biotechnology Industries Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Current Ratio?
How can you use the Current Ratio?
What is Clal Biotechnology Industries Ltd.'s Current Ratio?
How is the Current Ratio calculated for Clal Biotechnology Industries Ltd. (CBI.TA)?
What is the highest Current Ratio for Clal Biotechnology Industries Ltd. (CBI.TA)?
What is the 3-year average Current Ratio for Clal Biotechnology Industries Ltd. (CBI.TA)?
What is the 5-year average Current Ratio for Clal Biotechnology Industries Ltd. (CBI.TA)?
How does the current Current Ratio for Clal Biotechnology Industries Ltd. (CBI.TA) compare to its historical average?